Post
Komoh
Moderna Q3 Outlook: Moderna (MRNA) is set to report its Q3 results before the US market open on Nov 6, following a net loss of approximately $800M in Q2.
Market Sentiment: Sentiment on the prediction market "Will Moderna (MRNA) beat quarterly earnings?" leans heavily optimistic, with 94% voting "Yes" against 6% for "No" on a volume of 2.61M.
#ModernaQ3VaccineSales
Disclaimer: OKX Orbit content is provided for informational purposes only. Learn more
Replies
No comments yet. Be the first to reply!
Trending crypto
BTC/USDTBitcoin
$65,025.5+0.00%
ETH/USDTEthereum
$1,823.83+0.01%
SOL/USDTSolana
$71.6+0.01%
Today’s market buzz
1#NVIDIA contacts Arm CEO Haas, internally predicting new CEO candidate
2#US October PPI year-on-year 6.5% below expectations
3#Anthropic launches IPO roadshow, valuation rebounds to $1.8 trillion
